SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVerici Dx Share News (VRCI)

Share Price Information for Verici Dx (VRCI)

Share Price is delayed by 15 minutes
Get Live Data
0.375    0.00 (0.00%)
Bid:
0.35
Ask:
0.40
Spread: 0.05 (14.286%)
Market Cap: £8.30m
VRCI Live PriceLast checked at - London Stock Exchange

Intraday Verici Dx Share Chart

Verici Dx News

LONDON MARKET OPEN: Stocks rise as UK stays "cool and calm" on trade
10 Apr 2025

LONDON MARKET OPEN: Stocks rise as UK stays "cool and calm" on trade

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digest the latest developments in US President Donald Trump's trade w...

Verici Dx shares dive 58% as cuts outlook despite more Tutivia orders
7 Apr 2025

Verici Dx shares dive 58% as cuts outlook despite more Tutivia orders

(Alliance News) - Verici Dx PLC on Monday reported strong growth in test orders for its Tutivia diagnostic, ahead of an expected decision on US Medica...

Verici Dx reports record Tutivia orders, downgrades revenue outlook
7 Apr 2025

Verici Dx reports record Tutivia orders, downgrades revenue outlook

(Sharecast News) - Verici Dx has reported its highest-ever quarterly order rate for its Tutivia transplant diagnostic test in an update on Monday, wit...

Verici Dx delayed coverage determination pushes back Tutivia revenue
11 Oct 2024

Verici Dx delayed coverage determination pushes back Tutivia revenue

(Alliance News) - Verici Dx PLC on Friday said it was planning to submit supplemental information to Medicare, in order to support the delayed local ...

Verici Dx announces delay to Medicare determination for Tutivia test
11 Oct 2024

Verici Dx announces delay to Medicare determination for Tutivia test

(Sharecast News) - Verici Dx, a developer of advanced clinical diagnostics for organ transplants, announced an extension to its timeline for submittin...

AIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buys
11 Oct 2024

AIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buys

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises
15 Jul 2024

EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

IN BRIEF: Verici Dx hails milestone payment in deal with Thermo Fisher
1 Jul 2024

IN BRIEF: Verici Dx hails milestone payment in deal with Thermo Fisher

Verici Dx PLC - develops advanced clinical diagnostics for organ transplants - Notes that Thermo Fisher Scientific Inc confirms the completion of the ...